Mesoblast Limited (MESO) Stock Price Today
Aura AI Summary
Key Stats
- $2.15BMarket Cap
- -Volume
- TechnologySector
- $20.9652W High
- $13.1952W Low
- -Typical Hold Time
- $2.23BEnterprise Value
- -Div Yield
- -Trading Activity
Track Mesoblast Limited (MESO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Mesoblast Limited has traded between a low of $13.19 and a high of $20.96, highlighting its annual price range. Buy and sell Mesoblast Limited shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Most Recent News
Bitmine nears 5% ETH supply goal with $15.7B crypto holdings, driving strong Q3 gains and staking over 5M ETH.
Bitmine Immersion Technologies has accumulated 4.9% of the total Ethereum supply, holding $15.7 billion in crypto assets including 5.93 million ETH. The company has achieved 97% of its goal to acquire 5% of all ETH in just 15 months, contributing to ...

US sanctions Xinbi Guarantee, a Chinese-linked scam platform laundering $52M in crypto from Americans
The US Attorney for the District of Columbia announced sanctions against Xinbi Guarantee, an online platform used by Chinese cybercriminals to facilitate scams targeting Americans, including fraudulent cryptocurrency investments. Authorities restrain...

Jim Cramer favors Morgan Stanley over fintechs, praising its steady growth and $10T client assets milestone.
Jim Cramer expressed skepticism about the wave of new fintech and blockchain IPOs, describing many as similar and hard to differentiate. Instead, he highlighted Morgan Stanley as a strong, quietly executing incumbent that recently surpassed $10 trill...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.